Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BALDER APOTEK AS
AS
Active
Org 914283116
Munchs Gate 7, 0165 Oslo
Retail sale of pharmaceutical products · NACE 4773
Est. 2014
16 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 25M
-11% vs 2024
EBITDA margin
1.3%
-77% vs 2024
Equity ratio
22.1%
Financial strength
Net profit 2025
NOK 283K
-72% vs 2024
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2021
0M
-100%
2022
1M
+100%
2023
1M
0%
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
NOK 25M
-11%
EBITDA
NOK 326K
-77%
Net profit
NOK 283K
-72%
Total assets
NOK 4,6M
-13%
Equity
NOK 1M
-21%
Employees
16
—
Company information
Legal name
BALDER APOTEK AS
Org number
914283116
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
10. oktober 2014
Share capital
NOK 1 000 000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Drift av apotek og virksomhet som naturlig hører med til drift av apotek.
Contact
Address
Munchs Gate 7, 0165 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
8M
16M
24M
32M
19M
2021
20M
2022
25M
2023
28M
2024
25M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2021
0M
2022
1M
2023
1M
2024
0M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
18 627
20 208
24 602
27 949
25 012
Staff expenses
−3 476
−3 689
−3 609
−3 800
−4 047
EBITDA
500
439
1 451
1 444
326
Depreciation & amort.
−244
−257
−228
−121
−81
EBIT
257
182
1 223
1 324
244
Net financials
−3
−4
46
−5
81
Profit before tax
254
179
1 269
1 319
325
Tax
56
40
307
295
42
Net profit
198
139
961
1 024
283
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
4 749
3 718
6 421
5 268
4 580
Equity
1 166
1 095
1 156
1 280
1 013
Long-term debt
65
0
0
0
0
Short-term debt
3 518
2 623
5 265
3 988
3 567
Total debt
3 583
2 623
5 265
3 988
3 567
Financial ratios
5-year trend
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
2021
2025
Equity ratio
22.1%
This company
38.2%
Market median
-42% vs market
2021
2025
Return on equity
27.9%
This company
18.4%
Market median
+52% vs market
2021
2025
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
2021
2025
Asset turnover
5.46×
This company
1.12×
Market median
+387% vs market
2021
2025
Debt / equity
3.52×
This company
0.62×
Market median
-468% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
TI
Torleiv Idsøe Holst
Chairman
2015
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Similia As
Company
80.1%
80.1%
2022
Bjarne Brudeli
Individual
10%
10%
2022
Kamille Holding As
Company
9.9%
9.9%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
BALDER APOTEK AS
(this company)
NAMENA APOTEK AS
Board network connections
Board members of BALDER APOTEK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Torleiv Idsøe Holst
Chairman
0 companies